Form 4: Arteris Director Sells Shares Under 10b5-1 Plan

Arteris, Inc. Director Antonio J. Viana reported the sale of 20,000 shares of common stock for $26.11 per share, executed under a pre-established 10b5-1 trading plan.

Summary

• Director Antonio J. Viana sold 20,000 shares of Arteris, Inc. common stock on April 24, 2026.
• The sale was conducted at a weighted average price of $26.11 per share, with individual transactions ranging from $26.00 to $26.35.
• These shares were sold pursuant to a Rule 10b5-1(c) trading plan adopted on June 10, 2025.
• Following the transaction, Viana beneficially owns 124,620 shares of common stock, with 20,840 held directly and the remainder indirectly through the Viana Family Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While insider selling can be a negative signal, the execution under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic trading.

Positives

• The transaction was executed under a Rule 10b5-1 trading plan, indicating pre-planned and potentially non-insider trading related activity.
• The reporting person retains a significant beneficial ownership of 124,620 shares, suggesting continued commitment to the company.

Negatives

• A director has sold a notable number of shares, which could be perceived negatively by the market.
• The sale represents a reduction in direct beneficial ownership by a key insider.

Risks

• Potential for negative market perception due to insider selling, even if conducted under a 10b5-1 plan.
• The weighted average sale price indicates a range of prices, and the exact profit or loss on individual sales is not fully detailed without further information.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which solely reports a past transaction.

Management Comments

• The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the range set forth in footnote 2, upon request from the Issuer, any security holder, or the SEC staff.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. While sales by directors can sometimes signal a lack of confidence, the use of a Rule 10b5-1 plan suggests a structured approach to managing personal stock holdings, often implemented to avoid perceptions of insider trading.

Stakeholder Impact

• Shareholders may interpret the sale as a negative signal, potentially impacting short-term stock price.
• The Viana Family Trust, as an indirect beneficial owner, will see its holdings reduced.

Next Steps

• The reporting person may provide further details on individual share sale prices upon request.
• Continued monitoring of insider transactions for Arteris, Inc. is advisable.

Key Dates

Keywords

Arteris, Inc., Form 4, Insider Trading, 10b5-1 Plan, Stock Sale, Director Transaction, Beneficial Ownership, Common Stock